Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ThIRST DED: Diquafosol for Dry Eye in Cataract Surgery
NCT06146881Phase 2Unknown
- Sponsor
- Universitas Indonesia
- Start
- Oct 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of diquafosol in dry eye disease (DED) (2 arms), sponsored by Universitas Indonesia. Primary endpoints: Ocular Surface Disease Index Questionnaire at 4 months, Tear Break Up Time at 4 months and 7 more. Status: unknown.
02
Drugs
diquafosol
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT06146881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06146881.